Johan R. Boelaert
- Infectious Diseases top 0.5%
- Antimicrobial Resistance in Staphylococcus 14
- Antifungal resistance and susceptibility 14
- Tuberculosis Research and Epidemiology 9
- HIV/AIDS drug development and treatment 9
- Hematology top 0.5%
- Iron Metabolism and Disorders 18
- Genetics top 1%
- Hemoglobinopathies and Related Disorders 13
- Nephrology top 2%
- Virology top 2%
- HIV Research and Treatment 10
-
- Antibiotics Pharmacokinetics and Efficacy 13
- Co-authors
- R DaneelsH.W. Van LanduytVictor R. GordeukJ. Van CutsemStefaan J. VandecasteeleYves‐Jacques SchneiderM. SchurgersB. Gordts
- Journals
- The Lancet (1 paper)Journal of Clinical Investigation (1 paper)The Journal of Immunology (1 paper)
- Partner nations
- BelgiumUnited StatesItaly
In The Last Decade
Johan R. Boelaert
139 papers receiving 5.5k citations
Peers
Comparison fields: 5 of 143
- Infectious Diseases 2.2k
- Hematology 1.1k
- Genetics 791
- Nephrology 385
- Virology 236
Countries citing papers authored by Johan R. Boelaert
This map shows the geographic impact of Johan R. Boelaert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johan R. Boelaert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johan R. Boelaert more than expected).
Fields of papers citing papers by Johan R. Boelaert
This network shows the impact of papers produced by Johan R. Boelaert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johan R. Boelaert. The network helps show where Johan R. Boelaert may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Johan R. Boelaert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Circulating cytokines in pulmonary tuberculosis according to HIV status and dietary iron content. | 2009 | 14 |
| 2 | 2006 | 20 | |
| 3 | 2006 | 216 | |
| 4 | 2005 | 9 | |
| 5 | 2004 | 78 | |
| 6 | 2003 | 28 | |
| 7 | 2003 | 70 | |
| 8 | 2001 | 91 | |
| 9 | 2001 | 96 | |
| 10 | 2000 | 33 | |
| 11 | 1999 | 11 | |
| 12 | Iron chelation decreases human immunodeficiency virus-1 Tat potentiated tumor necrosis factor-induced NF-kappa B activation in Jurkat cells. | 1997 | 16 |
| 13 | In vitro effect of iron chelators on Mycobacterium Avium | 1997 | 1 |
| 14 | 1997 | 141 | |
| 15 | 1996 | 2 | |
| 16 | 1995 | 78 | |
| 17 | Staphylococcal infections. Workshop I: Discussion | 1994 | 1 |
| 18 | 1992 | 30 | |
| 19 | The use of nasal mupirocin ointment to prevent Staphylococcus aureus bacteraemias in haemodialysis patients: an analysis of cost- effectiveness | 1991 | 1 |
| 20 | 1990 | 43 |
About Johan R. Boelaert
Johan R. Boelaert is a scholar working on Infectious Diseases, Virology and Hematology, having authored 141 papers that have together received 5.8k indexed citations. Recurring topics across this work include Iron Metabolism and Disorders (18 papers), Antimicrobial Resistance in Staphylococcus (14 papers), Antifungal resistance and susceptibility (14 papers), Hemoglobinopathies and Related Disorders (13 papers), Antibiotics Pharmacokinetics and Efficacy (13 papers), HIV Research and Treatment (10 papers), Tuberculosis Research and Epidemiology (9 papers) and HIV/AIDS drug development and treatment (9 papers). The work is most often cited by research in Infectious Diseases (2.2k citations), Hematology (1.1k citations) and Genetics (791 citations). Johan R. Boelaert has collaborated with scholars based in Belgium, United States and Italy. Frequent co-authors include R Daneels, H.W. Van Landuyt, Victor R. Gordeuk, J. Van Cutsem, Stefaan J. Vandecasteele, Yves‐Jacques Schneider, M. Schurgers, B. Gordts, Jacques Piette and Kirk Sperber. Their work appears in journals such as The Lancet, Journal of Clinical Investigation and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.